Longitudinal study of tryptophan degradation during and after pregnancy

Life Sciences

Volumn 72, Issue 7, 2003, Pages 785-793

  Schröcksnadel, Katharina ^a   Widner, Bernhard ^a   Bergant, Anton ^b   Neurauter, Gabriele ^a,b   Schennach, Harald ^a   Schröcksnadel, Hans ^b   Fuchs, Dietmar ^a,b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Alanineaminotransferase; Indoleamine (2,3) dioxygenase; Kynurenine; Neopterin; Postpartum; Pregnancy; Soluble TNF receptor; Trypotophan

Indexed keywords

ALANINE AMINOTRANSFERASE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEOPTERIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; LONGITUDINAL STUDY; PLASMA; PREGNANCY; PROTEIN DEGRADATION;

ADULT; ALANINE TRANSAMINASE; ANTIGENS, CD; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KYNURENINE; LONGITUDINAL STUDIES; NEOPTERIN; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTERS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TRYPTOPHAN;

EID: 0037414726     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02304-4     Document Type: Article

References (29)

1. Byrne G.I., Lehmann L.K., Kirschbaum J.G., Borden E.C., Lee C.M., Brown R.R. Induction of tryptophan degradation in vitro and in vivo: A gamma interferon stimulated activity. Journal of Interferon Research. 49:1989;4941-4944.
2. Werner E.R., Hirsch-Kauffmann M., Fuchs D., Hausen A., Reibnegger G., Schweiger M., Wachter H. Interferon-gamma-induced degradation of tryptophan by human cells in vitro. Biological Chemistry Hoppe Seyler. 368:1987;1407-1412.
3. Werner E.R., Bitterlich G., Fuchs D., Hausen A., Reibnegger G., Szabo G., Dierich M.P., Wachter H. Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sciences. 41:1987;273-280.
4. Widner B., Ledochowski M., Fuchs D. Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. Current Drug Metabolism. 1:2000;193-204.
5. Freese A., Swartz K.J., During M.J., Martin J.B. Kynurenine metabolites of tryptophan: Implications for neurologic diseases. Neurology. 40:1990;691-695.
6. Pfefferkorn E.R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proceedings of the National Academy of Sciences (USA). 81:1984;908-912.
7. Ozaki Y., Edelstein M.P., Duch D.S. Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. Proceedings of the National Academy of Sciences (USA). 85:1988;1242-1246.
8. Fuchs D., Malkovsky M., Reibnegger G., Werner E.R., Forni G., Wachter H. Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunology Letters. 23:1989;103-108.
9. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., Mellor A.L. Inhibition of T-cell proliferation by macrophage tryptophan catabolism. Journal of Experimental Medicine. 189:1999;1363-1372.
10. Mellor A.L., Munn D.H. Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation? Immunology Today. 20:1999;469-473.
11. Munn D.H., Shafidazeh E., Attwood J.T., Bondarev I., Pashine A., Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 281:1998;1191-1193.
12. Mellor A.L., Munn D.H. Exstinguishing maternal immune responses during pregnancy: implications for immunosuppression. Seminars in Immunology. 13:2001;213-218.
13. Fuchs D., Möller A.A., Stöckle E., Reibnegger G., Werner E.R., Wachter H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and neurologic/psychiatric symptoms. Journal of Acquired Immune Deficiency Syndromes. 3:1990;873-876.
14. Widner B., Werner E.R., Schennach H., Wachter H., Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clinical Chemistry. 43:1997;2424-2426.
15. Widner B., Sepp N., Kowald E., Ortner U., Wirleitner B., Fritsch P., Baier-Bitterlich G., Fuchs D. Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology. 201:2000;621-630.
16. Giusti R.M., Maloney E.M., Hanchard B., Morgan O.S., Steinberg S.M., Wachter H., Williams E., Cranston B., Fuchs D., Manns A. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma. Cancer Epidemiology, Biomarkers and Prevention. 5:1996;699-704.
17. Denz H., Orth B., Weiss G., Herrmann R., Huber P., Wachter H., Fuchs D. Weight loss in patients with hematological neoplasias is associated with immune system stimulation. Clinical Investigator. 71:1993;37-41.
18. Schroecksnadel H., Baier-Bitterlich G., Dapunt O., Wachter H., Fuchs D. Decreased plasma tryptophan in pregnancy. Obstet. Gynecol. 88:1996;47-50.
19. Handley S.L., Dunn T.L., Waldron G., Baker J.M. Tryptophan, cortisol and puerperal mood. British Journal of Psychiatry. 136:1980;498-508.
20. Maes M., Ombelet W., Verkerk R., Bosmans E., Scharpe S. Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery- induced immune activation and early post-partum anxiety and depression. Psychological Medicine. 31:2001;847-858.
21. Maes M, Verkerk R, Bonaccorso S, Ombelet W. Depressive and anxiety symptoms in early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sciences (in press).
22. Arntzen K.J., Liabakk N.B., Jacobsen G., Espevik T., Austgulen R. Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at delivery. American Journal of Reproductive Immunology. 34:1995;163-169.
23. Kazda H., Taylor N., Healy D., Walker D. Maternal, umbilical, and amniotic fluid concentrations of tryptophan and kynurenine after labor or cesarean section. Pediatric Research. 44:1998;368-373.
24. Brew B.J., Dunbar N., Pemberton L., Kaldor J. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. Journal of Infectious Diseases. 174:1996;294-298.
25. Wiegand M., Möller A.A., Schreiber W., Krieg J.C., Fuchs D., Wachter H., Holsboer F. Nocturnal sleep in patients with HIV infection. European Archives of Psychiatry and Clinical Neuroscience. 240:1991;153-158.
26. Gard P.R., Handley S.L., Parsons A.D., Waldron G. A multivariate investigation of postpartum mood disturbance. Br Journal of Psychiatry. 148:1986;567-575.
27. Abou-Saleh M.T., Ghubash R., Karim L., Krymski M., Anderson D.N. The role of pterins and related factors in the biology of early postpartum depression. European Neuropsychopharmacology. 9:1999;295-300.
28. Evans J., Heron J., Francomb H., Oke S., Golding J. Cohort study of depressed mood during pregnancy and after childbirth. British Medical Journal. 323:2001;257-260.
29. Burns D.N., Nourjah P., Wright D.H., Minkoff H., Landesman S., Rubinstein A., Goedert J.J., Nugent R.P. Changes in immune activation markers during pregnancy and postpartum. Journal of Reproductive Immunology. 42:1999;147-165.